Universal Health Services director sells stock for $179,160

Maria Ruderman Singer, a director at Universal Health Services Inc. (NYSE:UHS), recently executed a sale of 1,000 shares of Class B Common Stock. The transaction, which took place on March 10, 2025, was completed at an average price of approximately $179.16 per share, totaling $179,160. According to InvestingPro data, UHS currently trades at an attractive P/E ratio of 10.12, with analysts setting price targets ranging from $176 to $280.

Earlier, on March 7, Singer acquired 5,000 shares through the exercise of stock options at a price of $67.69 per share. This acquisition was followed by the sale of 1,963 shares at a price of $172.42 per share to cover tax obligations. The company, with a market capitalization of $11.19 billion, maintains a "GREAT" financial health score according to InvestingPro’s comprehensive analysis.

After these transactions, Singer holds 7,916 shares of Universal Health Services. The transactions were filed in a Form 4 with the Securities and Exchange Commission. Seven analysts have recently revised their earnings estimates upward for the upcoming period, reflecting positive sentiment about the company’s prospects. Discover more insights and detailed analysis with a InvestingPro subscription, which includes access to the comprehensive Pro Research Report for UHS.

In other recent news, Universal Health Services (UHS) reported strong financial results for the fourth quarter of 2024, exceeding analyst expectations with an adjusted earnings per share (EPS) of $4.92, surpassing the forecast of $4.14. The company also reported revenue of $4.11 billion, which was $100 million above projections. In addition to these earnings highlights, Stephens raised its price target for Universal Health Services to $223 from $210, maintaining an Equal Weight rating. This upgrade comes as the company anticipates adjusted EBITDA-NCI growth of 7.8% at the midpoint of their 2025 guidance.

Universal Health Services is projecting a 5% to 6% increase in Acute top-line growth for 2025, driven by both price and volume changes, while its Same-Store Behavioral Health revenue is expected to grow by 6% to 8%. The company has also noted a stabilization in the labor market, with wage inflation and the use of temporary labor normalizing, which should contribute positively to financial performance. The company expects its Medicaid Disproportionate Share Hospital Payment Program benefit to be approximately $997 million in 2025, slightly down from $1.016 billion in 2024, due to prior period payments received last year.

Looking forward, UHS plans to continue its strategic expansion with new hospital openings, which are expected to be EBITDA positive. The company also highlighted a positive outlook for 2025, despite potential net benefits from pending programs in Tennessee and D.C. not yet being included in their projections. These developments reflect a stable operating environment and a strategic focus on expanding healthcare facilities and improving operational efficiencies.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.